| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |